Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bioverativ
Biotech
GBT adds 2 Sanofi sickle cell meds in deal worth up to $353M
In exchange for the global rights to the assets, Sanofi will receive up to $353 million in an upfront fee and milestone payments.
Amirah Al Idrus
Mar 16, 2021 9:55am
Sanofi nabs speedy review of sutimlimab
May 15, 2020 8:15am
Ex-Bioverativ CEO John Cox lands at Torque Therapeutics
Oct 2, 2019 7:43am